Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

B cells from chronic lymphocytic leukemia (CLL) patients are strong inducers of proliferation and major histocompatibility complex (MHC)-unrestricted [natural killer (NK)-like] cytotoxicity in normal T-lymphocytes

Abstract

We studied the ability of chronic lymphocytic leukemia (CLL) B cells to stimulate proliferation and major histocompatibility complex (MHC)-unrestricted [natural killer (NK)-like] cytotoxicity in a mixed lymphocyte tumor-cell culture (MLTC). CLL-derived B cells induced a significantly higher proliferative response than did B cells from healthy normal donors. Comparable levels of interferon and interleukin-2 production were detected in the mixed lymphocyte cultures (MLC) set up with normal B cells from healthy donors and in MLTC. Higher levels of NK-like cytotoxic activity were induced after stimulation with CLL than with normal B cells in nonlytic precursors. Inhibition experiments with specific monoclonal antibodies indicate that the NK-like response in MLTC is attributable to HLA class II antigens, which are expressed at comparable levels on CLL and normal B cells. Percoll gradient centrifugation of the MLC and MLTC recovered cells demonstrated that the NK-like effectors in both types of cultures were blast-transformed, highly mitotic cells.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Guy K, van Heyningen V: An ordered sequence of expression of human MHC class-II antigens during B cell maturation? Immunol Today 4:186–189, 1983

  2. 2.

    Nunez G, Giles RC, Ball EJ, Hurley CK, Capra JD, Statsuy P: Expression of HLA-DR, MB, MT and SB antigens on human mononuclear cells: Identification of two phenotypically distinct monocyte populations. J Immunol 133:1300–1306, 1984

  3. 3.

    Newman RA, Delia D, Greaves MF, Navarette C, Fainboim L, Festeinstein H: Differential expression of HLA-DR and DR linked determinants on human leukaemia and lymphoid cells. Eur J Immonol 13:172–177, 1983

  4. 4.

    Guy K, Ritchie AWS, van Heyningen V, Dewar AE: Further serological characterization of the heterogeneity of expression of human MHC class II antigens: Chronic lymphocytic leukemia cells and monocytes differentially express DR and DC antigens. Dis Markers 1:249–254, 1983

  5. 5.

    Swerdlaw H, Murray LJ, Habershaw JA, Stansfeld AG: Lymphocytic lymphoma B-chronic lymphocytic leukemia—an immunohistopathological study of peripheral B lymphocytic neoplasia. Br J Cancer 50:587–599, 1984

  6. 6.

    Guy K, Docherty LJM, Dewar AE: Deficient expression of MLC class II antigens in some cases of human B cell leukaemia. Clin Exp Immunol 63:290–297, 1986

  7. 7.

    Taramelli D, Fossati G, Balsari A, Marolda R, Parmiani G: The inhibition of lymphocyte stimulation by autologous human methastatic melanoma cells correlates with the expression of HLA-DR antigens on the tumor cells. Int J Cancer 34:797–784, 1984

  8. 8.

    Wallich R, Bulbuc N, Hmmerling GJ, Katzav S, Segal S, Feldman M: Abrogation of metastatic properties of tumour cells byde novo expression of H-2K antigens following H-2 gene transfection. Nature 305:771–775, 1985

  9. 9.

    Jones EH, Hockley AB, Lawler SD: Stimulation by CLL cells in mixed lymphocyte culture (MLC). Br J Cancer 44:675–681, 1981

  10. 10.

    Bom-van Noorloos AA, Schreuder I, de Groot-Swings G, Ubels-Postma J, vom dem Borne KR, Melief CJM: Variable MLC stimulatory capacity of neoplastic B and non-B non-T lymphocytes expressing HLA-DR antigens. Tissue Antigens 20:352–363, 1982

  11. 11.

    Halper PJ, Man Fu S, Gottlieb AB, Winchester RJ, Kunkel HG: Poor mixed lymphocyte reaction stimulatory capacity of leukemic B cells of chronic lymphocytic leukemia patients despite the presence of Ia antigens. J Clin Invest 64:1141–1148, 1979

  12. 12.

    Wolos JA, Davey FR: Function of lymphocyte subpopulations in chronic lymphocytic leukemia. Cancer 45:893–898, 1981

  13. 13.

    Wolos JA, Davey FR: B lymphocyte function in B cell chronic lymphocytic leukaemia. Br J Haematol 49:395–403, 1981

  14. 14.

    Lopez-Botet M, Silva A, Rodriguez J, De Landazuri MO: Generation of T-cell blasts with NK-like activity in human MLC: cellular precursors, IL 2 responsiveness, and phenotype expression. J Immunol 129:1109–1115, 1982

  15. 15.

    Matera L, Cardoso E, Caudana L, Moore M: Generation of non-MHC-restricted killing in non-cytotoxic T-lymphocytes from leukemia patients. Br J Haematol 65:151–157, 1987

  16. 16.

    Kedar E, De Landazuri M, Bonavida B: Cellular immunoadsorbents: A simplified technique for separation of lymphoid cell subpopulations. J Immunol 112:1231–1240, 1974

  17. 17.

    Santoli D, Francis MK, Matera L, Ferrero D: Induction of proliferation and NK activity in human lymphocytes by mature myelomonocytic cells: evidence for an HLA-DR-independent MLR stimulatory ability of terminally differentiated nonlymphoid leukemic cell lines and normal peripheral blood granulocytes. J Immunol 131:736–742, 1983

  18. 18.

    Santoli D, Defreitas EC, Sandberg-Wollheim M, Francis MK, Koprowsky H: Phenotypic and functional characterization of T cell clones derived from the cerebrospinal fluid of multiple sclerosis patients. J Immunol 132:2386–2392, 1984

  19. 19.

    Radka SF, Machamer CE, Cresswell P: Analysis of monoclonal antibodies reactive with human class II β-chains by two dimensional electrophoresys and western blotting. Hum Immunol 10:177–186, 1984

  20. 20.

    Hurley CK, Nunez G, Winchester R, Finn OJ, Levy R, Capra JD: The human HLA-DR antigens are encoded by multiple β-chain loci. J Immunol 129:2103–2108, 1982

  21. 21.

    Gillis S, Ferm MM, Ou W, Smith KA: T-cell growth factor: parameters of production and quantitative microassay for activity. J Immunol 120:2027–2032, 1978

  22. 22.

    Yeeth TJ, McBride PT, Overall JC, Green JA: An automated quantitative CPE-reduction interferon assay. J Clin Microbiol 127:1852–1859, 1981

  23. 23.

    Callawaert DM, Lightbody JJ, Kaplan J, Jaroszewsky J, Peterson WD, Rosemberg JC: Cytotoxicity of human peripheral lymphocytes in cell-mediated lympholysis: Antibody-dependent cell-mediated lympholysis and natural cytotoxicity assays after mixed lymphocyte culture. J Immunol 121:81–85, 1978

  24. 24.

    Seeley JK, Golub SH: Studies on cytotoxicity generated in human MLC. I. Time course and target spectrum of several concomitant cytotoxic activities. J Immunol 120:1415–1422, 1978

  25. 25.

    Bolhuis RLH, Ronteltap CPM: Generation of natural killer (NK) cell activity after mixed Lymphocyte culture (MLC). Activation of effector cells in NK-depleted cell populations. Immunol Lett 1:191–196, 1980

  26. 26.

    Santoli D, Francis MK, Trucco M: Phenotypic and functional characterization of allospecific and nonspecific (NK- and NK-like) cytotoxic T lymphocytes generated in human mixed lymphocyte cultures from noncytotoxic precursors. Cell Immunol 65:230–238, 1981

  27. 27.

    Masucci MG, Klein E, Argov S: Disappearance of the NK effect after explanation of lymphocytes and generation of similar nonspecific cytotoxicity correlated to the level of blastogenesis in activated cultures. J Immunol 124:2458–2463, 1980

  28. 28.

    Kuntz Crow M, Kunkel HG: Human dendritic cells: Major stimulators of the autologous and allogenic mixed leucocyte reactions. Clin Exp Immunol 49:338–346, 1982

  29. 29.

    Matera L, Francis MK, Herlyn M, Santoli D: Generation of NK-like activity in lymphocyte-tumor cell cultures. I. Role of HLA-DR antigens as stimulatory molecules. Nat Immun Cell Growth Regul 4:90–102, 1985

  30. 30.

    Timonen T, Ortaldo JR, Herberman RB: Analysis by a single cell cytotoxicity assay of natural killer cell frequencies among human large granular lymphocytes and of the effects of interferon on their activity. J Immunol 128:2514–2521, 1982

  31. 31.

    Lanier LL, Benike CJ, Phillips JH, Engleman EG: Recombinant interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu-7 and Leu-11 antigens. J Immunol 134:794–801, 1985

  32. 32.

    Matera L, Foa R, Malavasi F, Bellone G, Funaro A, Veglia F, Santoli D: Generation of non-MHC restricted killing in cultures stimulated with B cells from chronic lymphocytic leukaemia patients: Phenotypic characterization of the precursor and effector cells. Clin Exp Immunol 72:303–308, 1988

  33. 33.

    Pattengale PK, Gidlund M, Nilsson K, Sundstrm C, Sllstrm J, Simonsson B, Wigzell H: Lysis of fresh human B-lymphocyte-derived leukemia cells by interferon-activated natural killer (NK) cells. Int J Cancer 29:1–7, 1982

  34. 34.

    Reference to come.

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Matera, L., Foa, R., Massaia, M. et al. B cells from chronic lymphocytic leukemia (CLL) patients are strong inducers of proliferation and major histocompatibility complex (MHC)-unrestricted [natural killer (NK)-like] cytotoxicity in normal T-lymphocytes. J Clin Immunol 9, 329–337 (1989). https://doi.org/10.1007/BF00918665

Download citation

Key words

  • Chronic lymphocytic leukemia
  • natural killer (NK)-like cytotoxic activity
  • mixed lymphocyte culture
  • mixed lymphocyte tumor-cell culture